UNH Q1 Deep Dive: AI Investment and Value-Based Care Drive UnitedHealth’s Strong Start

Health insurance company UnitedHealth (NYSE:UNH) beat Wall Street’s revenue expectations in Q1 CY2026, with sales up 2% year on year to $111.7 billion. Its non-GAAP profit of $7.23 per share was 9.4% above analysts’ consensus estimates.

Is now the time to buy UNH? Find out in our full research report (it’s free for active Edge members).

StockStory’s Take

UnitedHealth delivered a positive first quarter, with management highlighting advances in pricing discipline, digital adoption, and operational improvements as central to the company’s performance. CEO Stephen Hemsley emphasized that actions taken in the prior year—including leadership refresh and targeted investments—are now producing results across all major business segments. Notably, the company’s focus on embedding value-based care and leveraging digital platforms led to improved patient outcomes and operational efficiency, as nearly half of UnitedHealthcare members now use digital tools for access and services.

Looking to the remainder of the year, UnitedHealth’s updated guidance is underpinned by continued investment in artificial intelligence (AI) and further expansion of value-based care models. Management believes that these strategies will enable more predictable care costs while improving patient and provider experiences. Chief Digital Officer Sandeep Dadlani stated, “All internal investments in AI use cases are routed through Optum Insight and have the potential to be commercialized outside of UnitedHealth Group,” reinforcing the expectation that both revenue growth and cost efficiencies will be driven by these ongoing digital initiatives.

Key Insights from Management’s Remarks

Management cited strong execution in digital transformation, pricing, and operational improvements as the main contributors to outperformance in the quarter.

• AI-Enabled Operations: The company has accelerated its $1.5 billion investment in AI, with early results showing improved productivity, reduced administrative burden, and faster prior authorization processing times. Nearly 95% of prior authorization requests are now submitted electronically, and about 50% are processed in real time, significantly reducing delays for patients and providers.
• Value-Based Care Expansion: Optum Health’s shift back to a disciplined, integrated value-based care model is producing measurable results. Management reported a 35% reduction in skilled nursing admissions in certain regions and a 12% increase in patient-facing hours, both attributed to operational focus and data-driven interventions.
• Leadership Refresh and Governance: Nearly half of UnitedHealth’s top 100 leadership roles have been refreshed, and new governance structures have been established, including a Public Responsibility Committee and a new Lead Independent Director. These changes are intended to strengthen oversight and strategic direction.
• Digital Engagement Growth: Member adoption of AI-powered digital tools continues to rise, with 73 million digital visits in the quarter—up 42% over two years. Over 80% of consumer contacts are now digital, leading to higher satisfaction and efficiency.
• Portfolio Focus and Divestitures: UnitedHealth completed the sale of its U.K. business and continues to narrow its focus on U.S. health care. Proceeds from divestitures are being used to support the United Health Foundation and other strategic initiatives, including expanding the health care workforce and improving rural health access.

Drivers of Future Performance

UnitedHealth’s outlook for the year is shaped by ongoing investment in AI, operational improvements, and disciplined cost management across its core businesses.

• AI and Digital Modernization: Management expects that enterprise-wide AI initiatives will drive both cost savings and new revenue opportunities, particularly through Optum Insight’s AI-first software platforms. These efforts are designed to streamline administrative processes, enhance care coordination, and create commercial offerings for external clients.
• Value-Based Care and Margin Recovery: The company continues to prioritize margin recovery in its Medicare and commercial businesses by focusing on product stability and improved pricing. Efforts to renegotiate contracts and optimize member mix are expected to support long-term sustainability, with special attention to government program funding alignment and care management in high-acuity populations.
• Regulatory and Legislative Risks: Management highlighted ongoing engagement with state and federal authorities regarding Medicaid and Medicare funding, as well as pharmacy benefit manager (PBM) legislation. The company sees risk in potential changes to reimbursement models, particularly the Medicare risk adjustment program, and is proactively advocating for policies that support value-based care and access.

Catalysts in Upcoming Quarters

In the coming quarters, our analysts will closely monitor (1) the pace of AI adoption and resulting operational efficiencies, (2) progress on margin recovery in Medicare and commercial insurance lines through pricing and contract renegotiations, and (3) the rollout and impact of value-based care initiatives within Optum Health. Additionally, we will track regulatory developments around Medicare risk adjustment and PBM legislation, which could influence both revenue streams and cost structures.

UnitedHealth currently trades at $345.05, up from $323.70 just before the earnings. Is the company at an inflection point that warrants a buy or sell? Find out in our full research report (it’s free).

High Quality Stocks for All Market Conditions

WHILE YOU’RE HERE: Top 9 Market-Beating Stocks. The best stocks don’t just beat the market once. They do it again. And again. Robust revenue growth, rising free cash flow, returns on capital that leave their competition in the dust. The market has already rewarded these businesses.

But our AI platform says the party isn’t over. Find out which 9 stocks made the cut this week — FREE. Get Our Top 9 Market-Beating Stocks for Free HERE.

Stocks that have made our list include now familiar names such as Nvidia (+1,326% between June 2020 and June 2025) as well as under-the-radar businesses like the once-micro-cap company Tecnoglass (+1,754% five-year return). Find your next big winner with StockStory today.